Recent Press Releases
Public Meetings
Reports & Presentations
Legislative Presentations
Archive Web Presentations
Stakeholder Newsletter
Texas Health Matters Weekly Columns

Sign Up for E-mail Updates

Office Closure logo

Health and Human Services Commission

AGENDA:

Pharmaceutical and Therapeutics Committee

Aug. 17, 2012
9 a.m.

Meeting Site:
Department of Aging and Disability Services
Winters Building
Public Hearing Room
701 West 51st St.
Austin

  1. Call to Order
  2. Approval of Minutes from April 13, 2012
  3. Old Business: Report on Health and Human Services Commission (HHSC) decisions on acceptance of the Pharmaceutical and Therapeutics Committee recommendations from the April 13, 2012 meeting
  4. New Business: Public Comment on Drug classes to be reviewed for the Medicaid preferred drug list (Drug Classes Listed Below)
    1. Antibiotics, Gastrointestinal
    2. Antihistamines, Minimally Sedating
    3. Antiparasitics, Topical
    4. Antivirals, Oral
    5. Calcium Channel Blockers
    6. Cephalosporins and Related Agents
    7. Cough and Cold
    8. Fluoroquinolones, Oral
    9. Growth Hormone
    10. Hepatitis C Agents
    11. Leukotriene Modifiers
    12. NSAIDS
    13. Ophthalmic Antibiotics
    14. Ophthalmic Antibiotic-Steroid Combinations
    15. Ophthalmics for Allergic Conjunctivitis
    16. Ophthalmics, Anti-Inflammatories
    17. Ophthalmics, Glaucoma Agents
    18. Otic Antibiotics
    19. Otic Anti-Infectives & Anesthetics
    20. Prenatal Vitamins
    21. Skeletal Muscle Relaxants

Public Comment on new drugs to be reviewed for the Medicaid PDL (Drugs Listed Below)

    1. Intranasal Rhinitis Agents — QNASL
    2. Steroids, Topical, Low Potency — Aqua Glycolic HC
    3. Sedative Hypnotics — Intermezzo
    4. Hypoglycemic, Incretin Mimetics/Enhancers — Janumet XR
    5. Hypoglycemic, Incretin Mimetics/Enhancers — Jentadueto
    6. Hypoglycemic, Incretin Mimetics/Enhancers — Bydureon
  1. Therapeutic and Clinical Drug Reviews and Updates: Paula L. Townsend, Pharm.D., Magellan Medicaid Administration
  2. Executive Work Session
    Pursuant to Texas Government Code, Chapter 531, and in accordance with Texas Administrative Code §§354.1928, the Pharmaceutical and Therapeutics Committee may meet in Executive Session on one or more items listed under New Business.
  3. Announcements of Drugs Recommended for the Medicaid Preferred Drug List
  4. Adjourn
  5. Next Meeting Date:  Nov. 16, 2012

Contact:   Julie Nieto, HHSC Medicaid/Children’s Health Insurance Program Division, 512-
491-1437, Julie.nieto@hhsc.state.tx.us.
                                                                                                                                   
This meeting is open to the public.  No reservations are required and there is no cost to attend this meeting.

People with disabilities who wish to attend the meeting and require auxiliary aids or services should contact Nieto at 512-491-1437 at least 72 hours before the meeting so appropriate arrangements can be made.